{"product_id":"hba1c-in-diabetes-9781444334449","title":"HbA1c in Diabetes","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eAdapting to the IFCC system of reporting HbA\u003csub\u003e1c\u003c\/sub\u003e poses a challenge to generations of health professionals who have learnt the percentage system related to the major clinical trials, in type 1 and type 2 diabetes, the DCCT and UKPDS. This handy paperback illuminates the transition path.  \u003cp\u003eUsing real-life case studies to illustrate actual clinical situations, the book shows you how to use mmol\/mol units in daily practice. Each case study shows the old percentage units alongside the IFCC units for quick comparison. Produced in association with Diabetes UK, this pocketbook helps you work with confidence in the IFCC system.\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTrade Review\u003c\/b\u003e\u003cbr\u003e\u003cp\u003e“The book, on the one hand, by working from the basics, is an excellent educational tool for those developing experience in the field of diabetes and on the other, through its real-life illustrations, can also be beneficial to the more experienced in facilitating the transition to use of the IFCC units of reporting.\"  (\u003ci\u003eAnnals of Clinical Biochemistry\u003c\/i\u003e, 1 September 2012)\u003c\/p\u003e “Using mainly case studies, this slim volume of 76 pages is an excellent aid to clinicians as they adjust to using the internationally recognised IFCC measurement which is replacing the current DCCT method of presenting HbA1c as a percentage of total Hb.” \u003ci\u003e(Practical Diabetes International, July 2010\u003c\/i\u003e)\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003eContributor list.  \u003cp\u003ePreface.\u003c\/p\u003e \u003cp\u003eAcknowledgements.\u003c\/p\u003e \u003cp\u003eForeword.\u003c\/p\u003e \u003cp\u003eAbbreviations.\u003c\/p\u003e \u003cp\u003eIntroduction.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCASE STUDIES.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e1 Diagnosis and early management of type 1 diabetes in a young child (\u003ci\u003eJulie A. Edge\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e2 Management of a very elderly client, housebound and living alone (\u003ci\u003eChris Cottrell and Helen Green\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e3 Gestational diabetes (2) (\u003ci\u003eJonathan Webber\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e4 Weight loss and improved glycaemic control (\u003ci\u003ePamela Dyson\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e5 Type 2 diabetes in a child (\u003ci\u003eTimothy G. Barrett\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e6 Weight reduction (\u003ci\u003eG. Pooler R. Archbold, Ailish Nugent, RW Henry\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e7 Improved glycaemic control (\u003ci\u003eSteve Creely\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e8 Risk of hypoglycaemia in a client in an elderly mentally ill unit in a nursing home (\u003ci\u003eChris Cottrell and Helen Green\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e9 Structured education for type 1 diabetes (\u003ci\u003ePamela Dyson\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e10 Woman with family history of raised cholesterol and diabetes (\u003ci\u003eRobert Cramb\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e11 Type 1 diabetes in a child (\u003ci\u003eTimothy G Barrett\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e12 Poor glucose control with microvascular complications (\u003ci\u003eSarah Griffiths and Parth Narendran\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e13 Renal failure and cardiovascular disease in an Asian patient (\u003ci\u003eAlex Wright\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e14 Type 1 diabetes in a teenage girl concerned about weight (\u003ci\u003eJulie A. Edge\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e15 Glycaemic control through patient empowerment (\u003ci\u003eYou Yi Hong, Maire O'Donnell, Sean Dinneen\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e16 Diagnosis and early management of type 2 diabetes in acute coronary syndrome (\u003ci\u003eMaggie Sinclair Hammersley and Daniel Hammersley\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e17 Incretin or insulin (\u003ci\u003eRichard Paisey\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e18 Type 2 diabetes and pregnancy (\u003ci\u003eNick Lewis-Barned\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e19 Deterioration of pre-existing diabetes in a patient on low dose quetiapine Valeria Frighi (\u003ci\u003eMatthew Stephenson\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e20 Low HbA1c and risk of hypoglycaemia (\u003ci\u003eJonathan Roland\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e21 Rapid changes in glycaemic control and retinopathy (\u003ci\u003eAdele Farnsworth and Alex Wright\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e22 Type 1 diabetes in a young man moving from paediatric to young adult services (\u003ci\u003eNick Lewis-Barned\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e23 Monitoring glycaemic control: HbA1c or fructosamine (\u003ci\u003eSarah Moore\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e24 Pre-pregnancy and pregnancy in type 1 diabetes (\u003ci\u003eCiara McLaughlin and David R. McCance\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e25 Maturity onset diabetes of the young, subtype HNF1A (HNF1A-MODY) (\u003ci\u003eAmanda Webster and Katharine R. Owen\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e26 'Overtreating' type 2 diabetes (\u003ci\u003eSimon Heller\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e27 Diabetes and an elevated triglyceride concentration (\u003ci\u003eRobert Cramb\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e28 Multiple therapies leading to bariatric surgery (\u003ci\u003eErnesto Lopez, R. David Leslie\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e29 Optic neuropathy (\u003ci\u003eRichard Paisey and Rob Willox\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e30 Uncertainty around the estimate of average plasma glucose from HbA1c (\u003ci\u003eEric S. Kilpatrick\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e31 Antipsychotics (\u003ci\u003eRichard I.G. Holt\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e32 Abnormal liver function in a patient with type 2 diabetes (\u003ci\u003eJoanne Morling\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e33 Fructosamine in diabetic nephropathy (\u003ci\u003eStuart A. Ritchie, John A. McKnight and Susan E. Manley\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e 34 Recurrent hypoglycaemia caused by secondary adrenal insufficiency (\u003ci\u003eAthinyaa Thiraviaraj, Hamza Ali Khan, Ailish G. Nugent, G. Pooler R. Archbold\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e35 A patient with diabetes taking niacin (\u003ci\u003eRichard Haynes and Jane Armitage\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e36 Tight glycaemic control leading to nocturnal hypoglyaemia (\u003ci\u003eRikke Borg\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e37 Diabetes and iron-deficiency anaemia (\u003ci\u003eW Garry John and Tara Wallace\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e38 Deterioration in vision after commencing insulin treatment (The early worsening phenomenon) (\u003ci\u003ePeter H Scanlon\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e39 Type 1 diabetes – Worsening glycaemic control on introduction of a pump? (\u003ci\u003eKen Sikaris\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e40 Monitoring glycaemic control in patient with sickle cell trait (\u003ci\u003eAndrea Gomes, Lis Chandler, Rachel Round and Janet Smith\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e41 Balancing fear of hypoglycaemia with optimal control in pregnancy (\u003ci\u003eRoy Taylor\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e42 Asian patient with high-risk feet and suboptimal glycaemic control (\u003ci\u003eVaradarajan Baskar\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e43 Type 2 diabetes and polycystic ovarian syndrome (\u003ci\u003eM Ali Karamat\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e44 Impact of variant haemoglobin AC on HbA1c determination (\u003ci\u003eLaura Hikin, Jackie Carr-Smith, Rachel Round and Janet Smith\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e45 Diabetic nephropathy (\u003ci\u003eSally M. Marshall\u003c\/i\u003e).\u003c\/p\u003e","brand":"John Wiley and Sons Ltd","offers":[{"title":"Default Title","offer_id":49408387842391,"sku":"9781444334449","price":33.2,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781444334449.jpg?v=1730502715","url":"https:\/\/bookcurl.com\/products\/hba1c-in-diabetes-9781444334449","provider":"Book Curl","version":"1.0","type":"link"}